Neal James R insider trades
Neal James R has filed 22 Form 4s with the SEC that we hold, for Processa Pharmaceuticals, Inc. (PCSA) (Director), Akari Therapeutics Plc (AKTX) (Director), Palisade Bio, INC. (PALI) (Director) and XOMA Royalty Corp (XOMA) (CEO, Director), among 5 companies in all. Across all of them we count 1 purchase worth $2.0K and 6 sales worth $2.3M reported on Form 4. In the last 12 months: 1 purchase ($2.0K) and 0 sales ($0). The largest single trade was a sale of 50,000 shares of XOMA Royalty Corp worth $1.5M, dated 2022-03-21. The first filing on our record is dated 2021-12-23 and the latest 2026-07-28.
Processa Pharmaceuticals, Inc. (PCSA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-03-31 | P, purchase reported on Form 4 | 789 | $2.0K | 2026-04-02 |
Akari Therapeutics Plc (AKTX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Palisade Bio, INC. (PALI)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
XOMA Royalty Corp (XOMA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-03-21 | S, sale reported on Form 4 | 50,000 | $1.5M | 2022-03-23 |
| 2022-03-22 | S, sale reported on Form 4 | 2,339 | $70.2K | 2022-03-23 |
| 2022-03-23 | S, sale reported on Form 4 | 1,111 | $33.4K | 2022-03-23 |
| 2022-07-15 | S, sale reported on Form 4 | 20,883 | $617.1K | 2022-07-18 |
| 2022-07-15 | S, sale reported on Form 4 | 3,212 | $100.2K | 2022-07-18 |
| 2022-07-15 | S, sale reported on Form 4 | 905 | $28.8K | 2022-07-18 |
PKBO
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1600865) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms